Life Sciences 2030 Report
We are witnessing an evolution of the life science sector both in the UK and internationally. Not only is the sector expanding rapidly but scientific developments are facilitating new techniques and product outputs.
The UK's quest to become a Scientific Superpower is being led by Life Sciences.
Major steps forward will be made in the coming decade, that seems certain, presenting huge opportunities for real estate investors and developers.
But the nature of scientific research is inherently uncertain. Making a deeper understanding of the sector's changing specialist requirements an essential part of Life Sciences' real estate investment.
Our Life Sciences 2030 report out today outlines how AI, robotics and specialist manufacturing will transform real estate requirements over the coming years, helping to direct development and investment into a sector on the brink of significant change.
The report explains why Biopharma, Diagnostics, Medical devices, Digital Health and Bioprocessing are our Ones to Watch in the 2020s.
And why being flexible and adaptable will help mitigate financial risk, support viability and maximise the opportunities presented by the UK’s exploding Life Sciences sector.
Credits: Bio-Innovation Centre, TusPark, Cambridge Science Park; Babraham Research Campus; Sherard Building, Oxford Science Park
Scientific advances with real estate implications
Cell and Gene therapies (CGT) are currently tipping the scales as the fastest growing area within the therapeutics market. Our latest report explores the evolution of CGT, market growth value, challenges, local considerations and real estate demands.